Vyxeos liposomal 44 mg/100 mg
Vyxeos liposomal 44 mg/100 mg is a medicine authorised by Swissmedic under authorisation number 68014. The authorisation holder is Jazz Pharmaceuticals Switzerland GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 17 February 2022 and the authorisation is limited until 16 February 2027. ATC code L01XY01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68014 |
|---|---|
| Name | Vyxeos liposomal 44 mg/100 mg |
| Full name | Vyxeos liposomal 44 mg/100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion |
| Authorisation holder | Jazz Pharmaceuticals Switzerland GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XY01 |
| First authorisation | 17 February 2022 |
| Authorisation validity | 16 February 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Vyxeos liposomal 44 mg/100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion | A | 17 February 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01XY01 | 07.16.1. | A |
| 2 | 2 | Durchstechflasche(n) | L01XY01 | 07.16.1. | A |
| 3 | 5 | Durchstechflasche(n) | L01XY01 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Vyxeos liposomal 44 mg/100 mg authorised in Switzerland?
Yes. Vyxeos liposomal 44 mg/100 mg is authorised by Swissmedic under authorisation number 68014, data as of 01 September 2026. The authorisation is limited until 16 February 2027.
Which dispensing category does Vyxeos liposomal 44 mg/100 mg have?
Vyxeos liposomal 44 mg/100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Vyxeos liposomal 44 mg/100 mg?
The authorisation holder is Jazz Pharmaceuticals Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.